This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Jonathan Andrew Taylor
Introduction
Jonathan Andrew Taylor is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work is characterized by a focus on innovative compounds that have the potential to impact medical treatments.
Latest Patents
One of Jonathan's key patents is titled "Oxepinopyrazole derivatives as inhibitors of P13-kinase activity." This invention is directed to compounds of formula (I), and salts thereof. The compounds are specifically designed to inhibit kinase activity, with a particular emphasis on PI3-kinase activity. This patent highlights his expertise in creating novel therapeutic agents.
Career Highlights
Jonathan is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research and development efforts. His work at this esteemed company allows him to collaborate with other leading scientists in the field.
Collaborations
Some of his notable coworkers include Andrew Baxter and Sophie Marie Bertrand. Their collective expertise contributes to the innovative environment at GlaxoSmithKline.
Conclusion
Jonathan Andrew Taylor's contributions to the field of kinase inhibitors exemplify the importance of innovation in pharmaceutical research. His work not only showcases his inventive spirit but also holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile